HealthpointCapital, LLC is a private equity investment firm established in 2002 and headquartered in San Diego, California. It specializes in the musculoskeletal healthcare sector, focusing on majority investments through buyouts, growth equity, and add-on transactions. The firm manages over $800 million in assets and has successfully completed 24 corporate acquisitions for its seven platform businesses, which include Alphatec Spine, BioHorizons Implant Systems, Blue Belt Technologies, China Rehabilitation, MicroDental, Nexa Orthopedics, and OrthoAccel Technologies. These companies are positioned in high-growth segments of the orthopedic industry, encompassing areas such as robotics, spine, dental, extremities, and emerging markets, reflecting HealthpointCapital's commitment to advancing healthcare innovation.
IlluminOss Medical, Inc. is a commercial-stage medical device company offering a unique, minimally invasive technology for fracture repair and stabilization. The Company utilizes a light-curable polymer contained within an expandable balloon to create a patient-conforming intramedullary implant for bone stabilization. The revolutionary, minimally invasive technology is particularly applicable for repair and treatment of patients with osteoporotic and compromised bone. The IlluminOss system is CE-marked and FDA-cleared for a variety of anatomical sites, with further indications pending.
CrossRoads Extremity Systems is a medical device manufacturing company that specializes in engineering foot and ankle implant systems. Using technology and materials, like high compression nitinol, our products are optimal for surgery. It was founded in 2014 and headquartered in Memphis, Tennessee.
OrthoAccel Technologies (OATI) designs, develops, markets, and sells the most revolutionary device in orthodontics – the Celerect 1000 – that cuts treatment time for braces in half and works in combination with all existing orthodontic bracket technologies. This proprietary technology (three issued patents) is licensed from the University of Illinois at Chicago and the company has engaged the leading researchers in this field including the inventor, Dr. Jeremy Mao, at Columbia University, Baylor College of Dentistry, and the University of Texas Health Sciences Center, Dental Branch. Together with these world-class partners, management will commercialize this innovation by 2009.
OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures. The company’s first product has the CE mark and is currently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
OrthoAccel Technologies (OATI) designs, develops, markets, and sells the most revolutionary device in orthodontics – the Celerect 1000 – that cuts treatment time for braces in half and works in combination with all existing orthodontic bracket technologies. This proprietary technology (three issued patents) is licensed from the University of Illinois at Chicago and the company has engaged the leading researchers in this field including the inventor, Dr. Jeremy Mao, at Columbia University, Baylor College of Dentistry, and the University of Texas Health Sciences Center, Dental Branch. Together with these world-class partners, management will commercialize this innovation by 2009.
OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures. The company’s first product has the CE mark and is currently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
OrthoAccel Technologies (OATI) designs, develops, markets, and sells the most revolutionary device in orthodontics – the Celerect 1000 – that cuts treatment time for braces in half and works in combination with all existing orthodontic bracket technologies. This proprietary technology (three issued patents) is licensed from the University of Illinois at Chicago and the company has engaged the leading researchers in this field including the inventor, Dr. Jeremy Mao, at Columbia University, Baylor College of Dentistry, and the University of Texas Health Sciences Center, Dental Branch. Together with these world-class partners, management will commercialize this innovation by 2009.
OrthoAccel Technologies (OATI) designs, develops, markets, and sells the most revolutionary device in orthodontics – the Celerect 1000 – that cuts treatment time for braces in half and works in combination with all existing orthodontic bracket technologies. This proprietary technology (three issued patents) is licensed from the University of Illinois at Chicago and the company has engaged the leading researchers in this field including the inventor, Dr. Jeremy Mao, at Columbia University, Baylor College of Dentistry, and the University of Texas Health Sciences Center, Dental Branch. Together with these world-class partners, management will commercialize this innovation by 2009.
OrthoAccel Technologies (OATI) designs, develops, markets, and sells the most revolutionary device in orthodontics – the Celerect 1000 – that cuts treatment time for braces in half and works in combination with all existing orthodontic bracket technologies. This proprietary technology (three issued patents) is licensed from the University of Illinois at Chicago and the company has engaged the leading researchers in this field including the inventor, Dr. Jeremy Mao, at Columbia University, Baylor College of Dentistry, and the University of Texas Health Sciences Center, Dental Branch. Together with these world-class partners, management will commercialize this innovation by 2009.
Bio-Lok International Inc is the worldwide manufacturer and distributor of the Micro-Lok & Silhouette Precision Dental Implant Systems. Silhouette & Micro-Lok are names synonymous with quality, fit of components, leading edge technology and design and finally, and as important, ease of use. All products are ISO 9001 , CE, EN46001 approved and are registered with the FDA and have over a 99% success rate . All components are manufactured in-house to aerospace tolerances. Although Bio-Lok offers a superior line of screw implants that incorporate many patented features, the “Silhouette”, both internal connection and hex-top tapered screw implants are becoming the implant of choice. They are committed to the development of optimum surfaces for the selective growth and attachment of tissue and bone. These technical advances will lead us into other areas of medicine and will allow Bio-Lok to evolve into a strong implant, bio-materials and bio-surfaces company.
DTI Dental Technologies
Acquisition in 2006
DTI Dental Technologies Inc. designs and manufactures dental prosthetics including crowns, bridges and orthodontic appliances.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.